Advertisements


Guardant Health to present precision oncology data at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2019

Sierra Oncology to present SRA737 preliminary clinical data at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Array may still present BEACON CRC data at ASCO, says Cowen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2019

Constellation Pharmaceuticals to present data from MANIFEST trial at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytMay 16th, 2019

AstraZeneca to present long-term follow-up data on CALQUENCE at ASCO meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2019

AstraZeneca to present new data from Phase III FLAURA trial at ASCO meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2019

Clovis to present four abstracts featuring data for Rubraca at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2019

Actinium Pharmaceuticals to present data on Phase 3 Iomab-B trial at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2019

Verastem to present Copiktra dose modification data at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Seattle Genetics to present data from six proprietary programs at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Atara Biotherapeutics to present Tab-cel data at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Celgene to present data from TRANSCEND trial at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Mylan, Biocon to present Ogivri OS data at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Forty Seven to present Phase 1B clinical trial data of 5F9 at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Vaccinex Reports First Quarter 2019 Financial Results and Provides Corporate Update

Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in.....»»

Category: earningsSource: benzingaMay 15th, 2019

Sierra Oncology Reports First Quarter 2019 Results

Momelotinib regulatory pathway clarity anticipated in Q2 2019 -- SRA737 Phase 1/2 preliminary clinical data anticipated at the 2019 ASCO Annual Meeting - VANCOUVER, May 8, 2019 /PRNewswire/ - Sierra Oncology, Inc. ("Sierra Oncology") (NASDAQ:.....»»

Category: earningsSource: benzingaMay 8th, 2019

DIGITAL HEALTH BRIEFING: Precision medicine is gaining momentum — AWS taps healthcare, finance for blockchain — Apps could solve medication adherence

Welcome to Digital Health Briefing, the newsletter providing the latest news, data, and insight on how digital technology is d.....»»

Category: topSource: businessinsiderApr 25th, 2018

Genentech to present new data from over 19 medicines at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 8th, 2018

HTG Molecular to feature HTG EdgeSeq Precision Immuno-Oncology Panel at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2018

AbbVie to present investigational oncology portfolio at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Agios to present new clinical data from IDH programs at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018